Part 10/12:
The story underscores the complex ethics surrounding medical advancements in weight management. While GLP-1 drugs like Ozempic represent a significant breakthrough, their widespread, often off-label, use raises concerns about health risks, dependency, and societal pressures.
The economics are also troubling. With medications costing thousands per month, some individuals turn to the black market, risking unregulated and potentially dangerous substances. The cases of people depleting savings, risking health, and becoming lifelong users highlight the dangers of viewing these drugs as a panacea rather than a tool to be used cautiously alongside lifestyle changes.